Humana Reports Second Quarter 2020 Financial Results; Continues Proactive Relief Efforts Amid Pandemic
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Humana (HUM) PT Raised to $425 at Cantor Fitzgerald
August 5, 2020 1:06 PM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Humana (NYSE: HUM) to $425.00 (from $410.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our OW rating on HUM and increase our price target to $425 from $410. On Wed., August 5, Humana reported better-than-expected... More
Humana (HUM) Tops Q2 EPS by $2.29, Offers FY Guidance
August 5, 2020 6:32 AM EDTHumana (NYSE: HUM) reported Q2 EPS of $12.56, $2.29 better than the analyst estimate of $10.27. Revenue for the quarter came in at $19.08 billion versus the consensus estimate of $18.63 billion.
GUIDANCE:
Humana sees FY2020 EPS of $18.25-$18.75, versus the consensus of $18.72.
Humana is revising its GAAP EPS guidance range for the year ending December 31, 2020 (FY 2020) to $17.36 to $17.86... More